Effect of non-adherence of evidence-based medication prescribing on major adverse cardiovascular events among acute coronary syndrome patients

Background and Aims: Combination therapy with evidence-based medicines, including 4 groups of medication: dual antiplatelet, beta-blocker, ACEI /ARB, and statin, could reduce the risk of morbidity and mortality among patients with the acute coronary syndrome (ACS). This retrospective cohort study aimed to compare the risk of major adverse cardiovascular events (MACE) including cardiovascular death, myocardial infarction, unstable angina, and stroke during the first year of discharge between ACS patients received 4 groups and those did not receive at least 1 medication group.
Source: Atherosclerosis - Category: Cardiology Authors: Source Type: research